GlycoMimetics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -12 | -14 | ||
EBITDA | -5,314 | -5,713 | -10,345 | -11,100 |
EBIT | -7,332 | -5,721 | -10,357 | -11,115 |
Net Income | -7,222 | -9,824 | -10,095 | -10,736 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,701 | -7,994 | -8,895 | -10,516 |
Cash | 10,720 | 14,391 | 22,386 | 31,281 |
Basic Shares | 64,477 | 64,483 | 64,483 | 64,457 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $10 | $74 | $1,160 |
Gross Profit | 10 | 74 | 1,160 | |
EBITDA | -40,039,378 | -39,121 | -47,195 | -63,182 |
EBIT | -39,275 | -47,403 | -63,447 | |
Net Income | -37,879 | -36,899 | -93,328 | -63,142 |
Net Change In Cash | 0 | 10 | 74 | 1,160 |
Free Cash Flow | -31,108,050 | -34,901 | -46,541 | -57,504 |
Cash | 10,720 | 41,792 | 47,871 | 90,255 |
Basic Shares | 64,477 | 63,342 | 52,531 | 51,453 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.15 |
2024-06-30 | -$0.16 |
2024-03-31 | -$0.17 |
2023-12-31 | -$0.14 |
